[Federal Register Volume 69, Number 71 (Tuesday, April 13, 2004)]
[Notices]
[Page 19583]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 04-8407]


-----------------------------------------------------------------------

SECURITIES AND EXCHANGE COMMISSION

[File No. 500-1]


Whispering Oaks International, Inc., D/b/a BioCurex, Inc.; Order 
of Suspension of Trading

April 8, 2004.
    It appears to the Securities and Exchange Commission that there is 
a lack of current and accurate information concerning the securities of 
Whispering Oaks International, d/b/a BioCurex, Inc. (``BioCurex''), 
because of questions regarding the accuracy of assertions by BioCurex 
and by others, in press releases and e-mails to investors concerning, 
among other things, (1) a study confirming the effectiveness of its 
primary product and (2) approval of its main product by the Food and 
Drug Administration.
    The Commission is of the opinion that the public interest and the 
protection of investors require a suspension of trading in the 
securities of the above listed company.
    Therefore, it is ordered, pursuant to section 12(k) of the 
Securities Exchange Act of 1934, that trading in the above listed 
company is suspended for the period from 3 p.m. EDT on April 8, 2004 
through 11:59 p.m. EDT on April 22, 2004.

    By the Commission.
J. Lynn Taylor,
Assistant Secretary.
[FR Doc. 04-8407 Filed 4-8-04; 8:45 am]
BILLING CODE 8010-01-P